Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eberhard Ritz

Showing results (201-210 of 334) with videos related to

Pageof 34
Sort By:
Pediatric Nephrology (Berlin, Germany)|March 13, 2009
Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in ratsKumiko Nakagawa, Niru Parekh, Nadezda Koleganova, et al.
American Journal of Physiology. Renal Physiology|April 25, 2008
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combinationGrzegorz Piecha, Nadezda Koleganova, Marie-Luise Gross, et al.
Kidney International|June 5, 2014
Development of the circadian clockwork in the kidneyKrisztina Mészáros, Linda Pruess, Attila J Szabó, et al.
Journal of Nephrology|May 22, 2007
Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidismJerzy Chudek, Anetta Nagy, Franciszek Kokot, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2009
Combining GFR and albuminuria to classify CKD improves prediction of ESRDStein I Hallan, Eberhard Ritz, Stian Lydersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.
American Journal of Physiology. Renal Physiology|March 7, 2002
Retinoid receptor-specific agonists alleviate experimental glomerulonephritisIngo Lehrke, Matthias Schaier, Kerstin Schade, et al.
Clinical Chemistry|March 13, 2010
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney diseaseKatharina-Susanne Spanaus, Barbara Kollerits, Eberhard Ritz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat modelJudith Adams, Giulio Odoni, Hiroaki Ogata, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 16, 2007
Frequency of albuminuria in primary care: a cross-sectional studyPeter Bramlage, David Pittrow, Hendrik Lehnert, et al.
Pageof 34

Showing results (201-210 of 334) with videos related to

Sort By:
Pageof 34
Pediatric Nephrology (Berlin, Germany)|March 13, 2009
Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in ratsKumiko Nakagawa, Niru Parekh, Nadezda Koleganova, et al.
American Journal of Physiology. Renal Physiology|April 25, 2008
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combinationGrzegorz Piecha, Nadezda Koleganova, Marie-Luise Gross, et al.
Kidney International|June 5, 2014
Development of the circadian clockwork in the kidneyKrisztina Mészáros, Linda Pruess, Attila J Szabó, et al.
Journal of Nephrology|May 22, 2007
Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidismJerzy Chudek, Anetta Nagy, Franciszek Kokot, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2009
Combining GFR and albuminuria to classify CKD improves prediction of ESRDStein I Hallan, Eberhard Ritz, Stian Lydersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.
American Journal of Physiology. Renal Physiology|March 7, 2002
Retinoid receptor-specific agonists alleviate experimental glomerulonephritisIngo Lehrke, Matthias Schaier, Kerstin Schade, et al.
Clinical Chemistry|March 13, 2010
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney diseaseKatharina-Susanne Spanaus, Barbara Kollerits, Eberhard Ritz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat modelJudith Adams, Giulio Odoni, Hiroaki Ogata, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 16, 2007
Frequency of albuminuria in primary care: a cross-sectional studyPeter Bramlage, David Pittrow, Hendrik Lehnert, et al.
Pageof 34